Company / Net Income
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Net Income History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$2.8M
FY2015
5-year range
-$2.8M / -$16.1K
FY2011-FY2015
Trend
-17055.7%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income changed -17056% YoY in FY2015, a notable deviation from the 3-year average annual change of -5685%.
Based on SEC 10-K filings.
-$3M in FY2015.
Declined from -$16,124 to -$3M over the past 3 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, net income decreased 17055.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | -$2.8M | -17055.7% |
| FY2013 | -$16.1K | +0.0% |
| FY2012 | -$16.1K | +0.0% |
| FY2011 | -$16.1K | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026